Search Dental Tribune

Nobel Biocare commences new era with Xeal and TiUltra surfaces

Hans Geiselhöringer, President and CEO of Nobel Biocare. (Photograph: Georg Isbaner, OEMUS MEDIA)

Wed. 13. March 2019


COLOGNE, Germany: Nobel Biocare has invited dental professionals to join the Mucointegration era with the launch of the Xeal and TiUltra surfaces at IDS 2019. Applied to not only implants but also abutments, these new surfaces have been created to optimise tissue integration at every level for the purpose of improving implant treatment outcomes.

With decades of expertise in applied anodisation technology, Nobel Biocare has recognised that, for the optimal integration of dental implant restorations, different tissues demand different surfaces. While osseointegration is fundamental for the long-term function of implant restorations, soft-tissue integration is often overlooked. Dense soft-tissue contact with the abutment, however, can act as a barrier to protect the underlying bone.

To maintain long-term tissue health and stability, the surface chemistry and topography of the new Xeal abutment were specially designed to facilitate soft-tissue attachment to the abutment. Backed by data from a clinical study with two-year follow-up, the Xeal surface has demonstrated a significant increase in soft-tissue height compared with machined abutment surfaces. This Mucointegration surface is available for the On1 Base and Multi-unit Abutment from Nobel Biocare, and dental professionals can see and experience Xeal in Cologne.

Developed with the ultimate goal of early osseointegration and long-term bone stability in mind, the ultra-hydrophilic, multi-zone implant surface TiUltra takes anodisation technology a step further. Going beyond just roughness, the surface chemistry was developed with the aim of positively influencing its interaction with cells and ultimately osseointegration. TiUltra’s topography has also been reimagined to change gradually from a minimally rough and non-porous collar to a moderately rough and porous implant apex, thus respecting the natural transition from hard, dense cortical bone to cancellous bone.

The TiUltra surface will be available for Nobel Biocare’s NobelActive and NobelParallel Conical Connection implants. Combined with the Xeal abutment surface, this will give dental professionals a new complete solution for soft-tissue health, bone protection and fast osseointegration.

To ensure that every implant and abutment is delivered in pristine condition, the surface chemistry and hydrophilicity of both Xeal and TiUltra are preserved with a protective layer that dissolves upon contact with fluids.

“Having mastered osseointegration for decades, Nobel Biocare is taking tissue integration to a new level. With the launch of Xeal and TiUltra at IDS Cologne, we are not only advancing our leadership position in surface technology but also introducing a new era for implant dentistry—that of Mucointegration,” commented Hans Geiselhöringer, President of Nobel Biocare, at the launch. “Our focus has always been on the patient. These new solutions are supported by clinical evidence, including a two-year clinical trial.”

Dental professionals in CE markets will be the first to gain access to the new surfaces, in April, followed by other regions around the globe.

An insight into the scientific evidence already available on the new surfaces will be published in a dedicated supplement of Clinical Implant Dentistry and Related Research, and seven studies are expected to be released online in March.

IDS attendees who wish to find out more about the features of Xeal and TiUltra are invited to visit Nobel Biocare's booth (#H020–J029) in Hall 10.1. The company also provides information online at

To post a reply please login or register